Omni Ab Status
The company was acquired by Ligand Pharmaceuticals (NAS:LGND) for $178 million on December 29, 2015. The deal included $92.6 million in cash and $85.4 million in Ligand common stock.
Profitable
Acquired/Merged (Operating Subsidiary)
Formerly VC-backed
The company was acquired by Ligand Pharmaceuticals (NAS:LGND) for $178 million on December 29, 2015. The deal included $92.6 million in cash and $85.4 million in Ligand common stock.
Most visits will take between 1.5 and 2 hours. The agenda for a specific visit depends on your group, its interests and objectives as well as on the host company. A visit may include a company or industry specific presentation, a discussion around a specific product or service, partnership opportunities, a demo, a meeting of the premises, etc.
Add a review